DRY POWDER INHALER WITH AN ADHERENCE/COMPLIANCE MONITOR

Abstract

A dry powder inhaler and an adherence and/or compliance monitor for use with the inhaler are provided. The inhaler has a cover which is pivotable relative to its housing in order to expose a mouthpiece. The monitor has one or more sensors. The inhaler and the monitor have formations for mounting the monitor onto the inhaler. The inhaler and monitor are designed so that when the monitor is mounted onto the housing of the inhaler and the cover is opened, the cover at least partially covers and protects the monitor.

Claims

1. A dry powder inhaler having a housing and a cover which is pivotable relative to the housing from a closed position to an open position in order to expose a mouthpiece, wherein the inhaler is designed for use with a monitor having one or more sensors, wherein the housing has one or more formations for mounting the monitor onto the inhaler, and wherein when the cover is in the open position, it at least partially covers the formations.

2. The dry powder inhaler according to claim 1, wherein the formations on the housing are accessible when the cover is in the closed position.

3. The dry powder inhaler according to claim 1, wherein the one or more formations are clip connections.

4. The dry powder inhaler according to claim 1, wherein the formations are adapted for detachably mounting the monitor onto the inhaler.

5. The dry powder inhaler according to claim 1, wherein the inside of the cover has one or more cams designed to operate switches on the monitor for determining the position and/or direction of motion of the cover.

6. The dry powder inhaler according to claim 1, wherein: in a first stage, moving the cover from the closed position to an intermediate position causes a blister strip to be advanced; in a second stage, moving the cover from the intermediate position to the open position causes a piercer to pierce an aligned blister.

7. The dry powder inhaler according to claim 1, wherein the monitor is mounted onto the inhaler, the monitor having a sensor and one or more formations for mounting the monitor onto the inhaler, wherein when the cover is in the open position, the cover at least partially covers the monitor.

8. The dry powder inhaler according to claim 7, wherein the one or more formations on the monitor are clip connections which connect with corresponding clip connections on the inhaler.

9. The dry powder inhaler according to claim 7, wherein the monitor is detachably mounted onto the inhaler.

10. The dry powder inhaler according to claim 7, which wherein the monitor has an inner face that matches the shape of the housing of the inhaler on which it is mounted and an outer face which corresponds to the curve defined by the rotation of the cover.

11. The dry powder inhaler according to claim 7, wherein the sensor is an optical sensor for reading a code on the blister strip and wherein in a first stage, moving the cover from the closed position to an intermediate position causes a blister strip to be advanced; in a second stage, moving the cover from the intermediate position to the open position causes a piercer to pierce an aligned blister.

12. The dry powder inhaler according to claim 7, wherein the inside of the cover has one or more cams designed to operate switches on the monitor for determining the position and/or direction of motion of the cover and wherein the monitor has switches on its outer side which are operated by the cams and further wherein the monitor is configured to determine the position and/or direction of motion of the cover based on the states of the switches.

13. The dry powder inhaler according to claim 7, wherein the monitor further comprises a pressure sensor for sensing a patient's inhalation on the mouthpiece.

14. The dry powder inhaler according to claim 7, wherein the monitor further comprises a controller and memory for processing and/or storing information from the sensor(s) and communication means for transmitting information to an external device.

15. A dry powder inhaler according to claim 1, and a monitor having a sensor and one or more formations for mounting the monitor onto the inhaler, so that when the monitor is mounted onto the inhaler and the cover is in the open position, the cover at least partially covers the monitor.

Description

BRIEF DESCRIPTION OF THE FIGURES

[0019] The invention will now be further described with reference to the Figures, wherein:

[0020] FIG. 1A shows a prior art adherence monitor for the Handihaler® inhaler.

[0021] FIG. 1B shows the monitor of FIG. 1A in place on the Handihaler®.

[0022] FIG. 2A shows a prior art adherence monitor for the Ellipta® inhaler.

[0023] FIG. 2B shows the monitor of FIG. 2A in place on the Ellipta®.

[0024] FIG. 3A shows a prior art adherence monitor for the Diskus® inhaler.

[0025] FIG. 3B shows the monitor of FIG. 3A in place on the Diskus®.

[0026] FIG. 4A shows an inhaler and a monitor according to the invention, with the cover in the closed position, so that the mouthpiece is covered.

[0027] FIG. 4B shows the inhaler of FIG. 4A with the cover in the open position so that the mouthpiece is exposed and the monitor is covered.

[0028] FIG. 4C shows the inhaler of FIG. 4A with the monitor removed and the cover open.

[0029] FIGS. 4D and 4E show the monitor removed from the inhaler.

[0030] FIG. 5A shows a second embodiment of the monitor that has switches on its outer side.

[0031] FIG. 5B shows a second embodiment of the mouthpiece cover that has cams on its inside that actuate the switches.

DETAILED DESCRIPTION OF THE INVENTION

[0032] In the context of dry powder inhalers, the term “adherence” is normally used to refer to whether the patient takes the prescribed number of doses per day, e.g. once or twice daily. The term “compliance” is normally used to refer to whether the patient uses their inhaler correctly, e.g. if they inhale sufficiently strongly to entrain the powder and disperse it into particles that reach the lung. Consequently, a monitor may be designed to measure adherence and/or compliance, according to the type of sensors that it uses, and how they are configured. In the present application, the term “monitor” therefore refers to a module having one or more sensors that is designed to measure and capture information relating to adherence and/or compliance. However, the monitor does not perform any of the functions associated with dosing the medication, such as a piercing or opening blisters/capsules, de-agglomerating the powder or providing a breath-actuation mechanism. The inhaler therefore operates to dispense powder whether the monitor is present or not.

[0033] WO 2016/111633 discloses detachable adherence monitors which have been retrospectively designed for specific dry powder inhalers, namely the Handihaler® and the Ellipta®, shown in FIGS. 1 and 2 respectively. WO 2014/204511 discloses adherence monitors for the Diskus® dry powder inhaler, shown in FIG. 3. FIGS. 1A, 2A, 3A show the monitors 100, 200, 300 alone; FIGS. 1B, 2B, 3B show them attached to the inhaler 110, 210, 310 in each case.

[0034] To attach the monitor 100 to the Handihaler® 110, the user has to slide the inhaler into the monitor at an angle, with the actuator button 130 first, so that the top edge of the inhaler fits under a retaining catch. Then outward pressure is applied to the monitor so that further retaining catches flex and allow the inhaler to fit into the monitor. The cover and mouthpiece may then be pivoted open to insert a capsule containing the powder. Then the actuator button 130 is pressed to pierce the capsule. The monitor has a switch 140 which is activated when the cover is opened/closed and a timer which records the time between opening and closing of the cap. If this time is in a defined range (such as between 3 and 10 seconds), then inhalation is deemed to have taken place.

[0035] The monitor 200 is attached to the Ellipta® inhaler 210 by an interference fit. The monitor has a switch 240 which is activated when the cover is opened/closed and a timer which records the time between opening and closing of the cap. It also has transparent sections 250 so that the label on the inhaler is not hidden. To operate the inhaler, the cover 220 is pivoted, which exposes the mouthpiece and also actuates the blister indexing and opening mechanism. The monitor may also have an acoustic sensor for detecting actuation or inhalation.

[0036] The monitor 300 for the Diskus® inhaler 310, may be configured as a clip that fits over the top and bottom portions of the inhaler. To operate the inhaler, the cover 320 is opened, then the actuator lever 330 is pressed. The monitor has motion sensors which determine whether or not the motion is characteristic of typical inhaler use. The monitor also has a temperature sensor 340 which can detect the presence of the patient's mouth at the mouthpiece.

[0037] In each case, since the monitors must not interfere with the cover or the actuator button/lever, they are designed to fit onto the other part of the inhalers, i.e. the part that the user holds during operation. Consequently, the patient must hold the monitor while operating the inhaler, resulting in a different user experience compared to the inhaler on its own. Moreover, the fact that the patent holds the monitor during inhalation can lead to inadvertent removal of the monitor or accidental damage to it.

[0038] An inhaler and monitor of the invention are shown in FIG. 4. FIG. 4A shows the inhaler with a monitor attached, and with the mouthpiece cover in the closed position. FIG. 4B shows the inhaler with the mouthpiece cover in the open position so that the mouthpiece is visible and so that the monitor is covered. FIG. 4C shows the inhaler with the monitor removed and with the mouthpiece cover in the open position. FIGS. 4D and 4E show the monitor detached from the inhaler.

[0039] The inhaler shown in FIG. 4 is an “open-inhale-close” inhaler of the type described in WO13/175177, which has a gear mechanism that selectively couples the mouthpiece cover to a blister strip indexing mechanism and also to a piercer. Moving the cover from the closed position to an intermediate position (the first stage of opening) causes the indexing mechanism to advance the blister strip. Then, once an unused blister is in position beneath the piercer, the indexing mechanism is disengaged. Moving the mouthpiece cover from the intermediate position to the fully open position (the second stage) causes the piercer to pierce the aligned blister. The user then inhales through the mouthpiece, which aerosolizes the powder in the pierced blister. However, the invention is not limited to this type of inhaler, and for example, could equally be used with an inhaler which has a passive mouthpiece cover, and a separate actuating lever, as described for example in WO13/175176, or with an inhaler which has a blister disk instead of a blister strip.

[0040] The inhaler of the invention preferably has a strip of blisters containing powdered medicament, and a mechanism for advancing the blister strip and for opening the blisters which is operated by an actuator. The opening mechanism is suitably a piercer which is mounted on the underside of the mouthpiece. The actuator drives the indexing mechanism to move a blister into alignment with the piercer and then moves the mouthpiece relative to the housing so that the piercer pierces the aligned blister. The actuator may be a lever which causes indexing of the blister strip and piercing of the blisters. Preferably however, the actuator is formed as part of, or is connected to, the cover, so that rotation of the cover causes indexing of the blister strip and piercing of the blisters. The inhaler may be configured to index and pierce one blister on each actuation. Alternatively, it may index and pierce two (or more) blisters on each actuation. For example, it may deliver two (or more) different formulations or medicaments simultaneously.

[0041] The inhaler 1 shown in FIG. 4 is constructed from two shell parts 2, 3 which are joined together to form a housing that contains a blister strip. A detachable monitor 40 is attached to one side of the inhaler. A mouthpiece cover 4 is mounted onto the housing. The cover 4 can be rotated through approximately 100° from the closed position (FIG. 4A) in which it covers and protects a mouthpiece, to a fully open position (FIG. 4B), in which the mouthpiece 5 is exposed so that the user can inhale a dose of medicament.

[0042] Once the monitor has been attached to the inhaler, the user does not need to touch it. When the cover is in the closed position, the monitor is located on a part of the inhaler which the patient does not hold when opening the cover (if the inhaler was held in this area, the patient's fingers would obstruct the opening movement of the cover). Consequently, the user interface is exactly the same as when the monitor is not present. Moreover, when the cover is in the open position for inhalation, the monitor is situated under the cover, so that it is protected from accidental damage or inadvertent removal.

[0043] The inner face of the monitor matches the shape of the housing of the inhaler on which it is mounted. The outer face is designed to correspond to the curve defined by the rotation of cover. In other words, it is shaped as an arc of a circle centred on the axis of rotation of the cover, with a radius which is slightly less than the radius of the internal surface of the cover. Thus, when the cover is opened there is a small clearance gap (about 0.5-1 mm) between the internal surface of the cover and outer face of the monitor. This maximises the volume of the monitor within the constraint that it must fit under the cover. By appearing as a continuation of the curve of the cover, the outer face also provides a visual cue to aid the user in mounting the monitor in the correct position.

[0044] FIG. 4C shows the inhaler with the monitor having been removed. An orifice 11 is visible in the wall 12 of the housing where the monitor was attached; its purpose is described below. A slot 13 for mounting the monitor is also visible. There is a second slot located towards the bottom of the wall 12, but this is not visible in FIG. 4C because it is hidden by the cover 4.

[0045] The monitor has an external optical sensor 44 located in a recess on its outer side, shown in FIG. 4D. This sensor is used to determine whether the mouthpiece cover has been fully opened. The cover has markings (e.g. moulded or embossed) on its internal surface which are read by the external optical sensor during the second stage of opening. Hence the monitor can determine whether the cover has been fully opened so that the blister was pierced, or whether actuation was aborted before piercing. This provides a further advantage for “open-inhale-close” inhalers: having the monitor located underneath the cover (when it is in the open position) provides a simple way of determining whether the patient has actually actuated the inhaler, or whether they have only partly opened the cover, and then closed it again. Two such sensors may be used, in combination with a two-part code on the inside of the cover. This allows the monitor to distinguish between four states, so that the direction of motion of the cover can be determined, as well as its position.

[0046] The inside face of the monitor (i.e. the side which abuts the inhaler when the monitor is attached) is shown in FIG. 4E. The monitor 40 has two clips 41 which fit into the corresponding slots 13 in the housing (only one of which is visible in FIG. 4C), and thereby hold the monitor in place when attached to the inhaler. The monitor has a pressure sensor 42, which is located in a recess on the inside face. The pressure sensor abuts the orifice 11, which leads via a channel in the housing to the mouthpiece. The monitor can thereby measure the pressure in the mouthpiece to detect the user's inhalation. The monitor also has three internal optical sensors 46 (for example photomicrosensors). These read a code on the blister strip (for example, a printed bar code), so that the number of doses that have been dispensed or that remain to be dispensed can be determined.

[0047] The monitor may be supplied separately from the inhaler, so that one monitor may be used with many different inhalers. The clips and slots allow the monitor to be detachably mounted on the inhaler by an interference fit. Alternatively, the monitor may be fixedly attached to the inhaler, in which case the clips can be welded onto the slots, e.g. by ultrasonic welding.

[0048] The position of the cover during the first stage of opening may be monitored by means of the optical sensors 46 on the inner side of the monitor which detect the motion of the code on the blister strip. Monitoring is handed over to the external optical sensor for the second stage in which the blister strip does not move. The external optical sensor is switched on shortly before the indexing mechanism is disengaged, at which point the cover has pivoted far enough to cover the outer optical sensor. This saves battery power because the external optical sensor is only switched on when needed. It also prevents false readings, which could otherwise occur e.g. if the user puts their fingers over the outer sensor.

[0049] In another embodiment, shown in FIGS. 5A and 5B, the monitor does not have an external optical sensor, but instead has two switches 81, 82. The inside of the cover has two corresponding cams 91, 92 which come into or out of contact with the switches as the cover is opened causing the switches to change state. Each cam causes two changes of state in each switch, so there are eight changes of switch state as the cover is fully opened. This provides two complete cycles of quadrature logic, which allow the monitor to determine the direction of motion of the cover (opening or closing). The switches and cams are arranged so that each change of switch state occurs at a different opening angle spanning both the first and second stages of the opening/closing motion. The monitor counts the changes in switch state and determines the position of the cover from the known angles at which the changes occur. Consequently, there is no need to use the motion of the blister strip to determine the position of the cover during the first stage of opening. Nonetheless, the monitor may have internal optical sensors for reading a code on the blister strip so that the monitor can determine the dose number. The cams and switches allow the monitor to determine whether the cover has been fully opened so that the blister was pierced, or whether actuation was aborted before piercing. The monitor may also have a pressure sensor for detecting inhalation.

[0050] This embodiment has the advantage that, due to the close fit between the inside of the cover and the outside of the monitor at all opening angles, the arrangement of cams and switches is simple to implement. Moreover, the power consumption of the monitor is reduced for two reasons. Firstly, there is no need for an external optical sensor. Secondly, the monitor can be switched on, or woken up from a sleep state, whenever one of the switches changes state. This avoids the need for the monitor to be permanently switched on.

[0051] The monitor may have a controller and memory (e.g. a suitable microprocessor) which are configured to process and/or store information read from the sensors relating to patient's usage of the inhaler. The monitor may also include communication means to transmit adherence/compliance information (e.g. via bluetooth) to an external device, such as a computer or smartphone. The information may then be displayed to the patient and/or a medical professional, by means of suitable software, for example a smartphone app. The information may additionally or alternatively be stored on the monitor for subsequent interrogation, or wirelessly transmitted to, for example, an online health platform.

[0052] The medicament is suitable for administration by inhalation, for example for the treatment of a respiratory disease. It may include one of more of the following classes of pharmaceutically active material: anticholinergics, adenosine A2A receptor agonists, β2-agonists, calcium blockers, IL-13 inhibitors, phosphodiesterase-4-inhibitors, kinase inhibitors, steroids, CXCR2, proteins, peptides, immunoglobulins such as Anti-IG-E, nucleic acids in particular DNA and RNA, monoclonal antibodies, small molecule inhibitors and leukotriene B4 antagonists. The medicament may include excipients, such as fine excipients and/or carrier particles (for example lactose), and/or additives (such as magnesium stearate, phospholipid or leucine).

[0053] Suitable β2-agonists include albuterol (salbutamol), preferably albuterol sulfate; carmoterol, preferably carmoterol hydrochloride; fenoterol; formoterol; milveterol, preferably milveterol hydrochloride; metaproterenol, preferably metaproterenol sulfate; olodaterol; procaterol; salmeterol, preferably salmeterol xinafoate; carmoterol; terbutaline, preferably terbutaline sulphate; vilanterol, preferably vilanterol trifenatate or indacaterol, preferably indacaterol maleate.

[0054] Suitable steroids include budesonide; beclamethasone, preferably beclomethasone dipropionate; ciclesonide; fluticasone, preferably fluticasone furoate; mometasone, preferably mometasone furoate. In one aspect, the method comprises jet milling mometasone, preferably mometasone furoate in the presence of a liquid aerosol.

[0055] Suitable anticholinergics include: aclidinium, preferably aclidinium bromide; glycopyrronium, preferably glycopyrronium bromide; ipratropium, preferably ipratropium bromide; oxitropium, preferably oxitropium bromide; tiotropium, preferably tiotropium bromide; umeclidinium, preferably umeclidinium bromide; Darotropium bromide; or tarafenacin.

[0056] The active material may include double or triple combinations such as salmeterol xinafoate and fluticasone propionate; budesonide and formoterol fumarate dihydrate glycopyrrolate and indacaterol maleate; glycopyrrolate, indacaterol maleate and mometasone furoate; fluticasone furoate and vilanterol; vilanterol and umclidinium bromide; fluticasone furoate, vilanterol and umclidinium bromide.